Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report

Gynecologic CancerRadio-Oncology

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Lancet.

Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ

doi: 10.1016/

Gynecologic Cancer

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

Eur J Cancer.

Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V

doi: 10.1016/j.ejca.2017.06.010.

High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report

Gynecol Oncol Rep.

Sears S, Singh S, Shojaei H, Redline R, Resnick K

doi: 10.1016/j.gore.2017.09.013.

Genitourinary Cancer

Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population

Clin Genitourin Cancer.

Robinson AG, Wei X, Vera-Badillo FE, Mackillop WJ, Booth CM

doi: 10.1016/j.clgc.2016.12.025.

Breast CancerGastrointestinal CancerGynecologic Cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

World J Surg Oncol.

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T, Yoshida K

doi: 10.1186/s12957-017-1185-5.

Gynecologic Cancer

Long-term survival with bevacizumab in heavily pretreated and platinum-resistant mucinous ovarian cancer: A case report

J Obstet Gynaecol Res.

Tarumi Y, Mori T, Matsushima H, Kokabu T, Tsuchiya H, Kitawaki J

doi: 10.1111/jog.13496.

Gynecologic Cancer

Effective treatment of a patient with stage IV ovarian cancer: A case report

Oncol Lett.

Huang Z, Yan H, Chavan D, Yuan Z, Yang X, Zhang Y, Song K, Kong B

doi: 10.3892/ol.2017.7285.

Lung, Respiratory and Thoracic CancerLymphoma

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Lancet Oncol.

Shaw AT, Kim TM, Crinò L, Gridelli C, Kiura K, Liu G, Novello S, Bearz A, Gautschi O, Mok T, Nishio M, Scagliotti G, Spigel DR, Deudon S, Zheng C, Pantano S, Urban P, Massacesi C, Viraswami-Appanna K, Felip E

doi: 10.1016/S1470-

Gastrointestinal CancerRadio-Oncology

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Lancet Oncol.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators, van Hazel G, Sharma RA

doi: 10.1016/

Related content

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report

Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

Long-term survival with bevacizumab in heavily pretreated and platinum-resistant mucinous ovarian cancer: A case report

Effective treatment of a patient with stage IV ovarian cancer: A case report

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials